Capnat (Capecitabine) — Patient Information Guide (UK)

Capnat is a medicine containing capecitabine, an oral chemotherapy medicine used to treat certain cancers. This page explains what Capnat is, how it works, how it is taken, and important safety information—written in a patient-friendly way for people in the United Kingdom.

Always follow the directions provided by your healthcare team. If anything here conflicts with your personal instructions, your healthcare team’s advice comes first.

Quick Product Information

What Is Capnat?

Capnat is a brand of capecitabine, a chemotherapy medicine that comes as tablets. It is used for several types of cancer, often as part of a planned course that may include other medicines (such as targeted therapies or other chemotherapy agents).

Capecitabine is designed to act mainly in cancer tissue. It becomes active after processing in the body, including within tumour cells. This helps it interfere with how cancer cells grow and divide.

How Capnat Works (Mechanism of Action)

Capecitabine is a prodrug, meaning it is converted into an active substance in the body. The active metabolite works by interfering with DNA synthesis.

• Capecitabine is converted to 5-fluorouracil (5-FU) through a sequence of steps involving liver and tumour-related enzymes.
• 5-FU and its active forms disrupt normal cell growth by blocking thymidylate synthase (needed to make DNA building blocks).
• It also interferes with RNA processing, further affecting how rapidly dividing cancer cells replicate.

Because many side effects relate to effects on rapidly dividing cells, common chemotherapy adverse effects can occur.

Pharmacokinetics (How the Body Handles It)

Pharmacokinetics describes absorption, distribution, metabolism, and elimination. Key points for capecitabine include:

• Absorption: After swallowing, capecitabine is absorbed through the gastrointestinal tract. Taking it with food can affect drug exposure.
• Activation: Conversion to 5-FU mainly happens in stages as the drug circulates, with additional activation in tumour tissue.
• Metabolism: It is metabolised into multiple inactive and active compounds. Enzymes involved in activation can vary between tissues.
• Elimination: Metabolites are cleared primarily through the kidneys and via breakdown pathways.
• Renal function matters: People with reduced kidney function may require dose adjustments and closer monitoring.

Typical Uses in the UK

Capnat (capecitabine) is used for several cancer types. Your exact treatment plan depends on the stage of disease, previous therapies, overall health, and treatment goals.

Common indications (general overview)

• Breast cancer: Capecitabine may be used in certain stages, including situations where the disease has progressed after prior treatment (as determined by your oncology team).
• Colorectal cancer: It is used in advanced or metastatic colorectal cancer, and also in some settings after surgery as part of adjuvant therapy.
• Gastric or gastro-oesophageal cancers: It may be used in certain regimens depending on the treatment plan.
• Other settings: Use may vary depending on country guidance, clinical protocols, and availability of combination regimens.

Not all indications apply to every patient. Your healthcare team can confirm why Capnat has been chosen for you.

How and When to Take Capnat (Timing & Administration)

Taking capecitabine correctly is important for effectiveness and safety. Always follow the schedule prescribed for you. A typical approach is taken in cycles, often with periods of treatment followed by rest.

General timing principles

• Take tablets at the times your prescriber specifies. Many regimens are taken twice daily (morning and evening).
• Take with food. Your instructions will specify how to take the doses with meals.
• Swallow whole with water. Do not crush or chew unless your healthcare team tells you otherwise.
• Keep the cycle schedule. Chemotherapy regimens often include “on” and “off” days.

If you miss a dose

If you miss a dose, follow your local guidance or the instructions from your oncology team. In general chemotherapy settings, missing or delaying doses can affect treatment. Many protocols recommend not taking extra doses to “catch up”. Contact your healthcare team or pharmacist for advice specific to your regimen.

Food Interactions and Meal Guidance

Food affects the absorption of capecitabine. For most patients, capecitabine is taken after food (for example, after a meal) to help ensure consistent drug levels.

Practical meal tips

• Aim to take your doses with or shortly after meals as directed.
• If nausea affects your ability to eat, speak to your healthcare team—there may be anti-sickness options.
• Avoid sudden large changes in your meal pattern without discussing it, especially if you notice side effects increasing.

Alcohol and Medicine Interactions

Alcohol

There is no single “safe amount” of alcohol that fits every patient on capecitabine. Alcohol may worsen side effects such as fatigue, nausea, and dehydration, and it can affect liver function in some individuals.

Best practice: it is generally advisable to limit or avoid alcohol during treatment unless your prescriber or pharmacist says it is acceptable for you.

Medicine interactions (important)

Capecitabine can interact with other medicines, which may increase side effects or change effectiveness. Tell your pharmacist about everything you take, including over-the-counter medicines, vitamins, and herbal products.

Examples of interactions that may matter

• Warfarin and other blood thinners: capecitabine may increase bleeding risk by affecting clotting control. Close INR monitoring may be needed.
• Phenytoin: levels may change, leading to toxicity or loss of control of seizures.
• Folinic acid (leucovorin): may increase the effects of fluoropyrimidines used in chemotherapy regimens.
• Allopurinol: may affect metabolism of chemotherapy-related compounds.
• Medicines affecting the immune system: combination regimens may require careful monitoring.
• Antacids: some antacid products can affect absorption; advice depends on your specific regimen.
• Other chemotherapy and targeted treatments: combining medicines can increase certain risks, requiring dose modifications.

Because the interaction profile depends on your full medication list and cancer regimen, always confirm with your pharmacist or oncology team.

Dose (General Guidance and What to Expect)

Capecitabine dosing is individualised based on factors such as: body surface area (BSA), cancer type, treatment plan, blood counts, kidney function, and tolerability.

Typical regimen patterns (examples)

• Many schedules are taken twice daily on set days within a cycle (for example, “days 1–14” followed by “rest days”).
• Dose strength and number of tablets depend on your prescribed dose and available tablet strengths.
• Dose may be adjusted due to side effects such as diarrhoea, low white blood cells, or hand-foot syndrome.

Your healthcare team will provide a clear dose schedule including: how many tablets per dose, which days to take them, and when to stop for a cycle break.

Adjustments for safety

Treatment may be delayed or reduced if blood tests or symptoms suggest that your body needs more time to recover. This is a normal part of chemotherapy safety.

Safety Profile: Common and Serious Side Effects

Like all medicines, capecitabine can cause side effects. Many are manageable with supportive care, dose adjustments, or temporary breaks. However, some symptoms can be urgent.

Common side effects

• Hand-foot syndrome (palmar-plantar erythrodysaesthesia): redness, swelling, pain, or peeling on hands/feet
• Diarrhoea and changes in bowel habits
• Nausea, vomiting, reduced appetite
• Mouth sores (stomatitis)
• Fatigue and weakness
• Low blood counts (anaemia, low white cells, low platelets)
• Skin changes, including dryness or rash
• Abdominal discomfort
• Hair thinning can occur, though this varies by regimen

Serious or urgent side effects — seek medical help promptly

Contact urgent care or your oncology team right away if you experience:

• Signs of infection: fever (often ≥ 38°C), chills, or feeling severely unwell
• Severe diarrhoea, especially if it persists or causes dehydration
• Severe mouth ulcers preventing you from eating or drinking
• Severe vomiting or inability to keep fluids down
• Signs of bleeding: unusual bruising, bleeding gums, blood in stools/urine
• Breathing problems or swelling of face/lips (possible allergic reaction)
• Severe hand-foot symptoms: blistering, sores, or inability to use hands/walk normally

When to monitor with blood tests

Your healthcare team will arrange regular blood tests to monitor: white blood cells, neutrophils, haemoglobin, and platelets, as well as kidney and liver function.

Practical Use Tips (Patient-Friendly)

The following tips can help you use Capnat safely and manage side effects more effectively. Always ask your pharmacist for advice tailored to you.

Hand-foot syndrome prevention

• Keep hands and feet moisturised with bland emollients (creams/ointments without irritants).
• Avoid friction and heat where possible: hot baths, harsh soaps, tight shoes, and strenuous activity.
• Wear comfortable footwear and use cushioned insoles if advised.
• Report early symptoms—tingling, redness, or soreness—so the team can act promptly (sometimes with dose changes).

Diarrhoea management

• Start hydration early if diarrhoea begins.
• Ask your pharmacist about anti-diarrhoea medicines you may use (some patients are given instructions on standby medication).
• Avoid foods that can worsen diarrhoea (for example, very spicy foods, high-fat meals, and alcohol).
• Seek urgent advice for severe diarrhoea or dehydration symptoms (dizziness, very dark urine, reduced urination).

Mouth care

• Use a soft toothbrush and gentle mouth rinses if advised.
• Avoid alcohol-containing mouthwashes if they sting or worsen irritation.
• Report mouth ulcers that prevent eating or drinking.

Nausea and appetite support

• Take meals in smaller portions and keep snacks to hand.
• Your team may prescribe anti-sickness medicines—take them as directed.

Oral chemotherapy handling and safety

• Keep tablets in their packaging until you are ready to take them.
• Wash hands after handling tablets. If someone else is helping you, ask how to handle and store tablets safely.
• Do not share medicine with others.
• Store at room temperature and in a place that children cannot access (follow your package instructions).

Alternative Options

“Alternative” depends on the cancer type, stage, previous treatments, and how well you tolerate therapy. Your oncology team may consider other chemotherapy agents or targeted treatments.

Possible alternatives (examples)

• Other oral fluoropyrimidines: similar chemotherapy approaches may be used depending on local guidance.
• Intravenous chemotherapy regimens: commonly used alternatives in colorectal and other cancers.
• Targeted therapies or immunotherapy (where appropriate): cancer-specific options may be available.
• Supportive or symptom-focused care: in some situations, treatment priorities may shift toward quality of life.

If you are considering changes, ask your healthcare team about the rationale for capecitabine and what other treatments might be suitable in your specific case.

UK Market & Legal Context (General)

In the United Kingdom, medicines such as capecitabine are typically classified as prescription-only medicines and are dispensed through regulated channels. Supply can be influenced by manufacturing schedules, distribution, and regional availability.

Online pharmacies in the UK must comply with applicable regulations for safe supply, information requirements, and pharmacy practice standards. If a medicine is temporarily out of stock, pharmacies may offer alternatives only in line with clinical and regulatory requirements.

Recent Guidance & Monitoring (What Patients Should Know)

Oncology care standards can evolve. Current best practice generally includes:

• Regular blood tests before and during treatment to guide dose changes.
• Early symptom reporting—especially for diarrhoea, mouth sores, fever, and hand-foot syndrome.
• Renal and liver monitoring—dose adjustments may be required for reduced kidney function.
• Clear cycle planning so patients understand on/off days and tablet counts.

Your oncology team will provide the specific plan for your regimen, including what to do if side effects occur.

Delivery, Availability & Ordering Notes (UK)

Availability of oncology medicines can vary. If Capnat is in stock, delivery times depend on your location and the courier service used by the pharmacy. If it is not immediately available, pharmacies may:

• Check alternative strengths or brands where clinically appropriate.
• Source from other distributors within regulated supply routes.
• Provide an expected delivery timeframe.

To avoid delays, ensure you order with enough time for your treatment schedule. If your cycle is about to start, contact the pharmacy team to confirm dispatch times.

Storage at home

• Store in a cool, dry place and keep out of sight and reach of children.
• Follow the package instructions for temperature and protection from light/conditions.
• If you’re unsure about storage, ask your pharmacist.

FAQ: Common Questions About Capnat (Capecitabine)

1) What should I do if I feel unwell after taking Capnat?

Many side effects are expected, but some require urgent attention—especially fever, severe diarrhoea, or signs of infection. Contact your oncology team or pharmacist if symptoms are severe, worsening, or concerning.

2) Can I take Capnat with food?

Capecitabine is usually taken after food as directed by your treatment plan. Eating as instructed helps ensure consistent absorption. Follow your specific schedule.

3) How long does a treatment cycle last?

Cycles vary by indication and regimen (often 2–3 weeks, sometimes longer). Your oncology team will provide a clear calendar showing “taking” and “rest” days.

4) What are the most important side effects to watch for?

Pay close attention to: fever/infection signs, diarrhoea, hand-foot syndrome, mouth sores, and symptoms of low blood counts.

5) Can I drive while taking Capnat?

Many people experience fatigue. If you feel tired, dizzy, or unwell, avoid driving and seek advice. Everyone’s response differs—use caution.

6) Are there any dietary restrictions?

There are no universal strict diets for capecitabine, but during side effects (diarrhoea, nausea, mouth irritation), certain foods may make symptoms worse. Stay hydrated and discuss nutrition support if appetite is poor.

7) Is it safe to take paracetamol?

Many people can use paracetamol for pain or fever, but it depends on your overall medical situation and other medicines. Check with your pharmacist before starting any new medicine, especially if you have liver concerns.

8) What should I do about other medicines I’m already taking?

Provide your pharmacist with a full list of medicines and supplements you use. Interaction risk varies, so confirm before starting or stopping anything.

9) Can I take vitamins or herbal products?

Some supplements and herbal remedies may interact with treatment. It’s safest to ask your pharmacist before taking them.

10) What if I accidentally take more tablets than prescribed?

Accidental overdosage can be dangerous. If this happens, contact urgent medical help or your pharmacy immediately for advice. Keep the tablet packaging available.

11) How is Capnat different from 5-fluorouracil (5-FU)?

Capecitabine is an oral prodrug that becomes 5-FU in the body. 5-FU is given directly by healthcare professionals in many regimens. They are related but are not interchangeable without medical guidance.

Summary

Capnat (capecitabine) is an oral chemotherapy medicine used in certain cancers. It works by interfering with DNA synthesis after conversion to active forms in the body. Its safety depends on correct dosing, timing with food, and close monitoring of side effects.

If you have questions about taking Capnat, managing symptoms, or checking for medicine interactions, speak to your pharmacist or oncology team. Early reporting of fever, severe diarrhoea, or serious symptoms can make a significant difference in staying safe during treatment.